Annual Debt To Equity
-0.78
-2.20-154.93%
31 December 2023
Summary:
NRx Pharmaceuticals annual debt to equity ratio is currently -0.78, with the most recent change of -2.20 (-154.93%) on 31 December 2023. During the last 3 years, it has fallen by -0.76 (-3800.00%). NRXPW annual debt to equity is now -154.93% below its all-time high of 1.42, reached on 31 December 2022.NRXPW Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-0.35
+0.07+16.67%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly debt to equity ratio is currently -0.35, with the most recent change of +0.07 (+16.67%) on 30 September 2024. Over the past year, it has increased by +1.27 (+78.40%). NRXPW quarterly debt to equity is now -153.85% below its all-time high of 0.65, reached on 31 December 2020.NRXPW Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -154.9% | +78.4% |
| 3 y3 years | -3800.0% | -683.3% |
| 5 y5 years | - | -600.0% |
NRXPW Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -154.9% | at low | -683.3% | +78.4% |
| 5 y | 5 years | -154.9% | at low | -153.8% | +78.4% |
| alltime | all time | -154.9% | at low | -153.8% | +78.4% |
NRx Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -0.35(-16.7%) |
| June 2024 | - | -0.42(-6.7%) |
| Mar 2024 | - | -0.45(-42.3%) |
| Dec 2023 | -0.78(-154.9%) | -0.78(-51.9%) |
| Sept 2023 | - | -1.62(-8200.0%) |
| Dec 2022 | 1.42(+7000.0%) | - |
| Mar 2022 | - | 0.02(0.0%) |
| Dec 2021 | 0.02 | 0.02(-66.7%) |
| Sept 2021 | - | 0.06(-250.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | -0.04(-106.2%) |
| Dec 2020 | -0.02(-106.5%) | 0.65(+132.1%) |
| Sept 2020 | - | 0.28(+47.4%) |
| June 2020 | - | 0.19(+26.7%) |
| Mar 2020 | - | 0.15(-51.6%) |
| Dec 2019 | 0.31 | 0.31(+342.9%) |
| Sept 2019 | - | 0.07(+75.0%) |
| June 2019 | - | 0.04(-86.7%) |
| Mar 2019 | - | 0.30 |
FAQ
- What is NRx Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual debt to equity year-on-year change?
- What is NRx Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly debt to equity year-on-year change?
What is NRx Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of NRXPW is -0.78
What is the all time high annual debt to equity for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual debt to equity ratio is 1.42
What is NRx Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, NRXPW annual debt to equity ratio has changed by -2.20 (-154.93%)
What is NRx Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of NRXPW is -0.35
What is the all time high quarterly debt to equity for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly debt to equity ratio is 0.65
What is NRx Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, NRXPW quarterly debt to equity ratio has changed by +1.27 (+78.40%)